Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 234

1.

Relationship between left ventricular ejection fraction and cardiovascular outcomes following hospitalization for heart failure: insights from the RELAX-AHF-2 trial.

Janwanishstaporn S, Feng S, Teerlink J, Metra M, Cotter G, Davison BA, Felker GM, Filippatos G, Pang P, Ponikowski P, Severin T, Gimpelewicz C, Holbro T, Chen CW, Sama I, Voors AA, Greenberg BH.

Eur J Heart Fail. 2020 Mar 5. doi: 10.1002/ejhf.1772. [Epub ahead of print]

PMID:
32141161
2.

Effects of serelaxin in patients admitted for acute heart failure: a meta-analysis.

Teerlink JR, Davison BA, Cotter G, Maggioni AP, Sato N, Chioncel O, Ertl G, Felker GM, Filippatos G, Greenberg BH, Pang PS, Ponikowski P, Edwards C, Senger S, Teichman SL, Nielsen OW, Voors AA, Metra M.

Eur J Heart Fail. 2020 Feb;22(2):315-329. doi: 10.1002/ejhf.1692. Epub 2019 Dec 30.

PMID:
31886953
3.

Clinical value of pre-discharge bio-adrenomedullin as a marker of residual congestion and high risk of heart failure hospital readmission.

Pandhi P, Ter Maaten JM, Emmens JE, Struck J, Bergmann A, Cleland JG, Givertz MM, Metra M, O'Connor CM, Teerlink JR, Ponikowski P, Cotter G, Davison B, van Veldhuisen DJ, Voors AA.

Eur J Heart Fail. 2019 Dec 3. doi: 10.1002/ejhf.1693. [Epub ahead of print]

PMID:
31797505
4.

Promoting colonoscopy screening among low-income Latinos at average risk of colorectal cancer: A randomized clinical trial.

DuHamel KN, Schofield EA, Villagra C, Sriphanlop P, Itzkowitz SH, Cotter G, Cohen N, Erwin DO, Winkel G, Thompson HS, Zauber AG, Jandorf LH.

Cancer. 2020 Feb 15;126(4):782-791. doi: 10.1002/cncr.32541. Epub 2019 Nov 19.

PMID:
31742670
5.

Insulin sensitizer MSDC-0602K in non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled phase IIb study.

Harrison SA, Alkhouri N, Davison BA, Sanyal A, Edwards C, Colca JR, Lee BH, Loomba R, Cusi K, Kolterman O, Cotter G, Dittrich HC.

J Hepatol. 2020 Apr;72(4):613-626. doi: 10.1016/j.jhep.2019.10.023. Epub 2019 Nov 4.

PMID:
31697972
6.

Is plasma renin activity associated with worse outcomes in acute heart failure? A secondary analysis from the BLAST-AHF trial.

Rachwan RJ, Butler J, Collins SP, Cotter G, Davison BA, Senger S, Ezekowitz JA, Filippatos G, Levy PD, Metra M, Ponikowski P, Teerlink JR, Voors AA, de Boer RA, Soergel DG, Felker GM, Pang PS.

Eur J Heart Fail. 2019 Dec;21(12):1561-1570. doi: 10.1002/ejhf.1607. Epub 2019 Oct 23.

PMID:
31646707
7.

Hepatorenal dysfunction identifies high-risk patients with acute heart failure: insights from the RELAX-AHF trial.

Biegus J, Demissei B, Postmus D, Cotter G, Davison BA, Felker GM, Filippatos G, Gimpelewicz C, Greenberg B, Metra M, Severin T, Teerlink JR, Voors AA, Ponikowski P.

ESC Heart Fail. 2019 Dec;6(6):1188-1198. doi: 10.1002/ehf2.12477. Epub 2019 Sep 30.

8.

Effects of Serelaxin in Patients with Acute Heart Failure.

Metra M, Teerlink JR, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Pang PS, Ponikowski P, Voors AA, Adams KF, Anker SD, Arias-Mendoza A, Avendaño P, Bacal F, Böhm M, Bortman G, Cleland JGF, Cohen-Solal A, Crespo-Leiro MG, Dorobantu M, Echeverría LE, Ferrari R, Goland S, Goncalvesová E, Goudev A, Køber L, Lema-Osores J, Levy PD, McDonald K, Manga P, Merkely B, Mueller C, Pieske B, Silva-Cardoso J, Špinar J, Squire I, Stępińska J, Van Mieghem W, von Lewinski D, Wikström G, Yilmaz MB, Hagner N, Holbro T, Hua TA, Sabarwal SV, Severin T, Szecsödy P, Gimpelewicz C; RELAX-AHF-2 Committees Investigators.

N Engl J Med. 2019 Aug 22;381(8):716-726. doi: 10.1056/NEJMoa1801291.

PMID:
31433919
9.

Safety, Tolerability and efficacy of Rapid Optimization, helped by NT-proBNP and GDF-15, of Heart Failure therapies (STRONG-HF): rationale and design for a multicentre, randomized, parallel-group study.

Kimmoun A, Cotter G, Davison B, Takagi K, Addad F, Celutkiene J, Chioncel O, Solal AC, Diaz R, Damasceno A, Duengen HD, Filippatos G, Goncalvesova E, Merai I, Metra M, Ponikowski P, Privalov D, Sliwa K, Sani MU, Voors AA, Shogenov Z, Mebazaa A.

Eur J Heart Fail. 2019 Nov;21(11):1459-1467. doi: 10.1002/ejhf.1575. Epub 2019 Aug 19.

PMID:
31423712
10.

Trajectories of Changes in Renal Function in Patients with Acute Heart Failure.

Beldhuis IE, Streng KW, van der Meer P, Ter Maaten JM, O'Connor CM, Metra M, Dittrich HC, Ponikowski P, Cotter G, Cleland JGF, Davison BA, Givertz MM, Teerlink JR, Bloomfield DM, Voors AA, Damman K.

J Card Fail. 2019 Nov;25(11):866-874. doi: 10.1016/j.cardfail.2019.07.004. Epub 2019 Jul 15.

11.

Therapeutic Advances in the Management of Acute Decompensated Heart Failure.

Antohi EL, Ambrosy AP, Collins SP, Ahmed A, Iliescu VA, Cotter G, Pang PS, Butler J, Chioncel O.

Am J Ther. 2019 Mar/Apr;26(2):e222-e233. doi: 10.1097/MJT.0000000000000919. Review.

12.

Serial assessment of spot urine sodium predicts effectiveness of decongestion and outcome in patients with acute heart failure.

Biegus J, Zymliński R, Sokolski M, Todd J, Cotter G, Metra M, Jankowska EA, Banasiak W, Ponikowski P.

Eur J Heart Fail. 2019 May;21(5):624-633. doi: 10.1002/ejhf.1428. Epub 2019 Feb 17.

PMID:
30773755
13.

Failure to Develop New Therapies in Acute Heart Failure-Is It Time to De-focus From Congestion?

Cotter G, Davison BA.

J Card Fail. 2018 Nov;24(11):793-794. doi: 10.1016/j.cardfail.2018.10.007. Epub 2018 Oct 18. No abstract available.

PMID:
30342903
14.

Processes of Change for Colonoscopy: Limited Support for Use Among Navigated Latinos.

Cotter G, DuHamel K, Schofield E, Jandorf L.

J Racial Ethn Health Disparities. 2019 Apr;6(2):327-334. doi: 10.1007/s40615-018-0528-4. Epub 2018 Oct 9.

PMID:
30302744
15.

Prevalence, clinical characteristics and outcomes of valvular atrial fibrillation in a cohort of African patients with acute heart failure: insights from the THESUS-HF registry.

Sani MU, Davison BA, Cotter G, Mayosi BM, Edwards C, Ogah OS, Damasceno A, Ojji DB, Dzudie A, Mondo C, Kouam CK, Suliman A, Yonga G, Ba SA, Maru F, Alemayehu B, Sliwa K.

Cardiovasc J Afr. 2018 May/Jun;29(3):139-145. doi: 10.5830/CVJA-2017-051.

16.

Unmodifiable events, heart failure research, and 'risk-based monitoring' in large studies-the unholy triumvirate.

Cotter G, Davison BA.

Eur J Heart Fail. 2018 Dec;20(12):1639-1644. doi: 10.1002/ejhf.1282. Epub 2018 Jul 27. Review. No abstract available.

17.

Prognostic Significance of Creatinine Increases During an Acute Heart Failure Admission in Patients With and Without Residual Congestion: A Post Hoc Analysis of the PROTECT Data.

Metra M, Cotter G, Senger S, Edwards C, Cleland JG, Ponikowski P, Cursack GC, Milo O, Teerlink JR, Givertz MM, O'Connor CM, Dittrich HC, Bloomfield DM, Voors AA, Davison BA.

Circ Heart Fail. 2018 May;11(5):e004644. doi: 10.1161/CIRCHEARTFAILURE.117.004644.

PMID:
29748350
18.

Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure.

Rubio-Gracia J, Demissei BG, Ter Maaten JM, Cleland JG, O'Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Davison BA, Givertz MM, Bloomfield DM, Dittrich H, Damman K, Pérez-Calvo JI, Voors AA.

Int J Cardiol. 2018 May 1;258:185-191. doi: 10.1016/j.ijcard.2018.01.067.

19.

Increased blood lactate is prevalent and identifies poor prognosis in patients with acute heart failure without overt peripheral hypoperfusion.

Zymliński R, Biegus J, Sokolski M, Siwołowski P, Nawrocka-Millward S, Todd J, Jankowska EA, Banasiak W, Cotter G, Cleland JG, Ponikowski P.

Eur J Heart Fail. 2018 Jun;20(6):1011-1018. doi: 10.1002/ejhf.1156. Epub 2018 Feb 12.

20.

Site enrollment rate, outcomes, and study drug effects in a multicenter trial. Results from RELAX-AHF.

Metra M, Davison BA, Gimpelewicz C, Carubelli V, Felker GM, Filippatos G, Greenberg BH, Hua TA, Liu Z, Pang PS, Ponikowski P, Severin TM, Voors AA, Wang Y, Cotter G, Teerlink JR.

Int J Cardiol. 2018 Feb 15;253:91-96. doi: 10.1016/j.ijcard.2017.09.185.

PMID:
29306479
21.

Proportional pulse pressure relates to cardiac index in stabilized acute heart failure patients.

Petrie CJ, Ponikowski P, Metra M, Mitrovic V, Ruda M, Fernandez A, Vishnevsky A, Cotter G, Milo O, Laessing U, Zhang Y, Dahlke M, Zymlinski R, Voors AA.

Clin Exp Hypertens. 2018;40(7):637-643. doi: 10.1080/10641963.2017.1416121. Epub 2017 Dec 21.

PMID:
29265934
22.

Relationship between baseline systolic blood pressure and long-term outcomes in acute heart failure patients treated with TRV027: an exploratory subgroup analysis of BLAST-AHF.

Cotter G, Davison BA, Butler J, Collins SP, Ezekowitz JA, Felker GM, Filippatos G, Levy PD, Metra M, Ponikowski P, Teerlink JR, Voors AA, Senger S, Bharucha D, Goin K, Soergel DG, Pang PS.

Clin Res Cardiol. 2018 Feb;107(2):170-181. doi: 10.1007/s00392-017-1168-0. Epub 2017 Oct 6.

PMID:
28986703
23.

Systolic blood pressure reduction during the first 24 h in acute heart failure admission: friend or foe?

Cotter G, Metra M, Davison BA, Jondeau G, Cleland JGF, Bourge RC, Milo O, O'Connor CM, Parker JD, Torre-Amione G, van Veldhuisen DJ, Kobrin I, Rainisio M, Senger S, Edwards C, McMurray JJV, Teerlink JR; VERITAS Investigators.

Eur J Heart Fail. 2018 Feb;20(2):317-322. doi: 10.1002/ejhf.889. Epub 2017 Sep 4.

24.

RELAX-AHF, BLAST-AHF, TRUE-AHF, and other important truths in acute heart failure research.

Cotter G, Cohen-Solal A, Davison BA, Mebazaa A.

Eur J Heart Fail. 2017 Nov;19(11):1355-1357. doi: 10.1002/ejhf.934. Epub 2017 Aug 24. No abstract available.

25.

Effects of serelaxin on the outcome of patients with or without substantial peripheral edema: A subgroup analysis from the RELAX-AHF trial.

Gimpelewicz C, Metra M, Cleland JGF, Szecsödy P, Chang Wun CC, Boer-Martins L, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Pang P, Ponikowski P, Severin T, Voors AA, Teerlink JR.

Am Heart J. 2017 Aug;190:113-122. doi: 10.1016/j.ahj.2017.05.012. Epub 2017 May 27.

26.

Erratum to: Serelaxin in acute heart failure patients with and without atrial fibrillation: a secondary analysis of the RELAX-AHF trial.

Filippatos G, Farmakis D, Metra M, Cotter G, Davison BA, Felker GM, Greenberg BH, Hua TA, Pang PS, Ponikowski P, Qian M, Severin TA, Voors AA, Teerlink JR.

Clin Res Cardiol. 2017 Nov;106(11):938. doi: 10.1007/s00392-017-1139-5. No abstract available.

27.

Plasma Neutrophil Gelatinase-Associated Lipocalin and Predicting Clinically Relevant Worsening Renal Function in Acute Heart Failure.

Damman K, Valente MAE, van Veldhuisen DJ, Cleland JGF, O'Connor CM, Metra M, Ponikowski P, Cotter G, Davison B, Givertz MM, Bloomfield DM, Hillege HL, Voors AA.

Int J Mol Sci. 2017 Jul 8;18(7). pii: E1470. doi: 10.3390/ijms18071470.

28.

Identifying Subpopulations with Distinct Response to Treatment Using Plasma Biomarkers in Acute Heart Failure: Results from the PROTECT Trial : Differential Response in Acute Heart Failure.

Liu LCY, Valente MAE, Postmus D, O'Connor CM, Metra M, Dittrich HC, Ponikowski P, Teerlink JR, Cotter G, Davison B, Cleland JGF, Givertz MM, Bloomfield DM, van Veldhuisen DJ, Hillege HL, van der Meer P, Voors AA.

Cardiovasc Drugs Ther. 2017 Jun;31(3):281-293. doi: 10.1007/s10557-017-6726-1.

29.

A network analysis to compare biomarker profiles in patients with and without diabetes mellitus in acute heart failure.

Sharma A, Demissei BG, Tromp J, Hillege HL, Cleland JG, O'Connor CM, Metra M, Ponikowski P, Teerlink JR, Davison BA, Givertz MM, Bloomfield DM, Dittrich H, van Veldhuisen DJ, Cotter G, Ezekowitz JA, Khan MAF, Voors AA.

Eur J Heart Fail. 2017 Oct;19(10):1310-1320. doi: 10.1002/ejhf.912. Epub 2017 Jun 21.

30.

Biomarker Profiles of Acute Heart Failure Patients With a Mid-Range Ejection Fraction.

Tromp J, Khan MAF, Mentz RJ, O'Connor CM, Metra M, Dittrich HC, Ponikowski P, Teerlink JR, Cotter G, Davison B, Cleland JGF, Givertz MM, Bloomfield DM, Van Veldhuisen DJ, Hillege HL, Voors AA, van der Meer P.

JACC Heart Fail. 2017 Jul;5(7):507-517. doi: 10.1016/j.jchf.2017.04.007. Epub 2017 Jun 14.

31.

Benefit of cardiopoietic mesenchymal stem cell therapy on left ventricular remodelling: results from the Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) study.

Teerlink JR, Metra M, Filippatos GS, Davison BA, Bartunek J, Terzic A, Gersh BJ, Povsic TJ, Henry TD, Alexandre B, Homsy C, Edwards C, Seron A, Wijns W, Cotter G; CHART Investigators.

Eur J Heart Fail. 2017 Nov;19(11):1520-1529. doi: 10.1002/ejhf.898. Epub 2017 May 31.

32.

Biased ligand of the angiotensin II type 1 receptor in patients with acute heart failure: a randomized, double-blind, placebo-controlled, phase IIB, dose ranging trial (BLAST-AHF).

Pang PS, Butler J, Collins SP, Cotter G, Davison BA, Ezekowitz JA, Filippatos G, Levy PD, Metra M, Ponikowski P, Teerlink JR, Voors AA, Bharucha D, Goin K, Soergel DG, Felker GM.

Eur Heart J. 2017 Aug 7;38(30):2364-2373. doi: 10.1093/eurheartj/ehx196.

33.

Day vs night: Does time of presentation matter in acute heart failure? A secondary analysis from the RELAX-AHF trial.

Pang PS, Teerlink JR, Boer-Martins L, Gimpelewicz C, Davison BA, Wang Y, Voors AA, Severin T, Ponikowski P, Hua TA, Greenberg BH, Filippatos G, Felker GM, Cotter G, Metra M.

Am Heart J. 2017 May;187:62-69. doi: 10.1016/j.ahj.2017.02.024. Epub 2017 Feb 22.

34.

Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 study.

Teerlink JR, Voors AA, Ponikowski P, Pang PS, Greenberg BH, Filippatos G, Felker GM, Davison BA, Cotter G, Gimpelewicz C, Boer-Martins L, Wernsing M, Hua TA, Severin T, Metra M.

Eur J Heart Fail. 2017 Jun;19(6):800-809. doi: 10.1002/ejhf.830. Epub 2017 Apr 28.

35.

Measurement of troponin and natriuretic peptides shortly after admission in patients with heart failure-does it add useful prognostic information? An analysis of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Studies (VERITAS).

Cleland JGF, Teerlink JR, Davison BA, Shoaib A, Metra M, Senger S, Milo O, Cotter G, Bourge RC, Parker JD, Jondeau G, Krum H, O'Connor CM, Torre-Amione G, van Veldhuisen DJ, McMurray JJV; VERITAS Investigators.

Eur J Heart Fail. 2017 Jun;19(6):739-747. doi: 10.1002/ejhf.786. Epub 2017 Mar 10.

36.

Echocardiographic predictors of outcome in acute heart failure patients in sub-Saharan Africa: insights from THESUS-HF.

Sani MU, Davison BA, Cotter G, Damasceno A, Mayosi BM, Ogah OS, Mondo C, Dzudie A, Ojji DB, Kouam CK, Suliman A, Yonga G, Ba SA, Maru F, Alemayehu B, Edwards C, Sliwa K.

Cardiovasc J Afr. 2017 Jan/Feb;28(1):60-67. doi: 10.5830/CVJA-2016-070.

37.

Plasma biomarkers to predict or rule out early post-discharge events after hospitalization for acute heart failure.

Demissei BG, Postmus D, Cleland JG, O'Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Davison BA, Givertz MM, Bloomfield DM, van Veldhuisen DJ, Dittrich HC, Hillege HL, Voors AA.

Eur J Heart Fail. 2017 Jun;19(6):728-738. doi: 10.1002/ejhf.766. Epub 2017 Mar 1.

38.

Serelaxin in acute heart failure patients with and without atrial fibrillation: a secondary analysis of the RELAX-AHF trial.

Filippatos G, Farmakis D, Metra M, Cotter G, Davison BA, Felker GM, Greenberg BH, Hua TA, Pang PS, Ponikowski P, Qian M, Severin TA, Voors AA, Teerlink JR.

Clin Res Cardiol. 2017 Jun;106(6):444-456. doi: 10.1007/s00392-016-1074-x. Epub 2017 Feb 1. Erratum in: Clin Res Cardiol. 2017 Jul 27;:.

39.

A multimarker multi-time point-based risk stratification strategy in acute heart failure: results from the RELAX-AHF trial.

Demissei BG, Cotter G, Prescott MF, Felker GM, Filippatos G, Greenberg BH, Pang PS, Ponikowski P, Severin TM, Wang Y, Qian M, Teerlink JR, Metra M, Davison BA, Voors AA.

Eur J Heart Fail. 2017 Aug;19(8):1001-1010. doi: 10.1002/ejhf.749. Epub 2017 Jan 30.

40.

Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial.

Bartunek J, Terzic A, Davison BA, Filippatos GS, Radovanovic S, Beleslin B, Merkely B, Musialek P, Wojakowski W, Andreka P, Horvath IG, Katz A, Dolatabadi D, El Nakadi B, Arandjelovic A, Edes I, Seferovic PM, Obradovic S, Vanderheyden M, Jagic N, Petrov I, Atar S, Halabi M, Gelev VL, Shochat MK, Kasprzak JD, Sanz-Ruiz R, Heyndrickx GR, Nyolczas N, Legrand V, Guédès A, Heyse A, Moccetti T, Fernandez-Aviles F, Jimenez-Quevedo P, Bayes-Genis A, Hernandez-Garcia JM, Ribichini F, Gruchala M, Waldman SA, Teerlink JR, Gersh BJ, Povsic TJ, Henry TD, Metra M, Hajjar RJ, Tendera M, Behfar A, Alexandre B, Seron A, Stough WG, Sherman W, Cotter G, Wijns W; CHART Program.

Eur Heart J. 2017 Mar 1;38(9):648-660. doi: 10.1093/eurheartj/ehw543.

41.

Sex differences in early dyspnea relief between men and women hospitalized for acute heart failure: insights from the RELAX-AHF study.

Meyer S, Teerlink JR, Metra M, Ponikowski P, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Hua TA, Severin T, Qian M, Voors AA.

Clin Res Cardiol. 2017 Apr;106(4):280-292. doi: 10.1007/s00392-016-1051-4. Epub 2016 Nov 12.

42.

Serum Potassium Levels and Outcome in Acute Heart Failure (Data from the PROTECT and COACH Trials).

Tromp J, Ter Maaten JM, Damman K, O'Connor CM, Metra M, Dittrich HC, Ponikowski P, Teerlink JR, Cotter G, Davison B, Cleland JG, Givertz MM, Bloomfield DM, van der Wal MH, Jaarsma T, van Veldhuisen DJ, Hillege HL, Voors AA, van der Meer P.

Am J Cardiol. 2017 Jan 15;119(2):290-296. doi: 10.1016/j.amjcard.2016.09.038. Epub 2016 Oct 8.

43.

Use of biomarkers to establish potential role and function of circulating microRNAs in acute heart failure.

Vegter EL, Schmitter D, Hagemeijer Y, Ovchinnikova ES, van der Harst P, Teerlink JR, O'Connor CM, Metra M, Davison BA, Bloomfield D, Cotter G, Cleland JG, Givertz MM, Ponikowski P, van Veldhuisen DJ, van der Meer P, Berezikov E, Voors AA, Khan MA.

Int J Cardiol. 2016 Dec 1;224:231-239. doi: 10.1016/j.ijcard.2016.09.010. Epub 2016 Sep 11.

44.

In-hospital worsening heart failure in patients admitted for acute heart failure.

Carubelli V, Cotter G, Davison B, Gishe J, Senger S, Bonadei I, Gorga E, Lazzarini V, Lombardi C, Metra M.

Int J Cardiol. 2016 Dec 15;225:353-361. doi: 10.1016/j.ijcard.2016.10.002. Epub 2016 Oct 5.

PMID:
27756041
45.

Symptoms and Signs of Heart Failure at Admission and Discharge and Outcomes in the Sub-Saharan Acute Heart Failure (THESUS-HF) Registry.

Sani MU, Cotter G, Davison BA, Mayosi BM, Damasceno A, Edwards C, Ogah OS, Mondo C, Dzudie A, Ojji DB, Kouam Kouam C, Suliman A, Yonga G, Abdou Ba S, Maru F, Alemayehu B, Sliwa K.

J Card Fail. 2017 Oct;23(10):739-742. doi: 10.1016/j.cardfail.2016.09.016. Epub 2016 Sep 21.

PMID:
27664511
46.

Clinical Correlates and Prognostic Value of Proenkephalin in Acute and Chronic Heart Failure.

Matsue Y, Ter Maaten JM, Struck J, Metra M, O'Connor CM, Ponikowski P, Teerlink JR, Cotter G, Davison B, Cleland JG, Givertz MM, Bloomfield DM, Dittrich HC, van Veldhuisen DJ, van der Meer P, Damman K, Voors AA.

J Card Fail. 2017 Mar;23(3):231-239. doi: 10.1016/j.cardfail.2016.09.007. Epub 2016 Sep 20.

47.

Blood urea nitrogen-to-creatinine ratio in the general population and in patients with acute heart failure.

Matsue Y, van der Meer P, Damman K, Metra M, O'Connor CM, Ponikowski P, Teerlink JR, Cotter G, Davison B, Cleland JG, Givertz MM, Bloomfield DM, Dittrich HC, Gansevoort RT, Bakker SJ, van der Harst P, Hillege HL, van Veldhuisen DJ, Voors AA.

Heart. 2017 Mar;103(6):407-413. doi: 10.1136/heartjnl-2016-310112. Epub 2016 Sep 22.

PMID:
27658757
48.

Risk-based evaluation of efficacy of rolofylline in patients hospitalized with acute heart failure - Post-hoc analysis of the PROTECT trial.

Demissei BG, Postmus D, Liu LCY, Cleland JG, O'Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Davison BA, Edwards C, Givertz MM, Bloomfield DM, Dittrich HC, Voors AA, Hillege HL.

Int J Cardiol. 2016 Nov 15;223:967-975. doi: 10.1016/j.ijcard.2016.08.271. Epub 2016 Aug 19.

PMID:
27589047
49.

Hypochloremia, Diuretic Resistance, and Outcome in Patients With Acute Heart Failure.

Ter Maaten JM, Damman K, Hanberg JS, Givertz MM, Metra M, O'Connor CM, Teerlink JR, Ponikowski P, Cotter G, Davison B, Cleland JG, Bloomfield DM, Hillege HL, van Veldhuisen DJ, Voors AA, Testani JM.

Circ Heart Fail. 2016 Aug;9(8). pii: e003109. doi: 10.1161/CIRCHEARTFAILURE.116.003109.

PMID:
27507112
50.

Acute heart failure in the young: Clinical characteristics and biomarker profiles.

Tromp J, Meyer S, Mentz RJ, O'Connor CM, Metra M, Dittrich HC, Ponikowski P, Teerlink JR, Cotter G, Davison B, Cleland JG, Givertz MM, Bloomfield DM, van Veldhuisen DJ, Hillege HL, Voors AA, van der Meer P.

Int J Cardiol. 2016 Oct 15;221:1067-72. doi: 10.1016/j.ijcard.2016.06.339. Epub 2016 Jul 5.

Supplemental Content

Loading ...
Support Center